MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Zimmer Biomet Holdings Company Profile (NYSE:ZBH)

Consensus Ratings for Zimmer Biomet Holdings (NYSE:ZBH) (?)
Ratings Breakdown: 1 Sell Rating(s), 4 Hold Rating(s), 16 Buy Rating(s)
Consensus Rating:Buy (Score: 2.71)
Consensus Price Target: $123.63 (0.46% upside)

Analysts' Ratings History for Zimmer Biomet Holdings (NYSE:ZBH)
Show:
DateFirmActionRatingPrice TargetActions
5/25/2016ArgusUpgradeHold -> Buy$140.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/22/2016Jefferies GroupReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/16/2016Sterne Agee CRTReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/2/2016Leerink SwannBoost Price TargetOutperform$124.00 -> $135.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2016OppenheimerReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2016Morgan StanleyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2016BarclaysReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016Canaccord GenuityReiterated RatingBuy$150.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016Needham & Company LLCReiterated RatingBuy$129.00 -> $134.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/15/2016RBC CapitalBoost Price TargetOutperform$120.00 -> $132.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/8/2016Goldman SachsLower Price Target$113.00 -> $111.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/20/2016Bank of AmericaInitiated CoverageBuy$127.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/17/2016NomuraInitiated CoverageBuy$123.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/16/2016Piper JaffrayReiterated RatingOverweight$125.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/31/2016William BlairReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2016Northland SecuritiesLower Price Target$109.00 -> $105.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/27/2016JMP SecuritiesBoost Price TargetMarket Outperform$118.00 -> $125.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/12/2015Citigroup Inc.Initiated CoverageSell$92.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/30/2015Brean CapitalReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/9/2015BMO Capital MarketsLower Price Target$132.00 -> $120.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/9/2015Credit SuisseInitiated CoverageOutperform$107.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/29/2015Deutsche BankReiterated RatingHold$114.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/30/2015Robert W. BairdUpgradeNeutral -> Outperform$110.00 -> $125.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/9/2015SunTrustDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/5/2015JPMorgan Chase & Co.UpgradeNeutral -> Overweight$120.00 -> $136.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/24/2014Cantor FitzgeraldBoost Price Target$117.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/29/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha